Ivan Kovačević

Ivan Kovačević holds the title of Assistant Professor at Singidunum University (since 2021) and has extensive professional experience in pharmacovigilance, regulatory affairs, and academia. He previously worked at GlaxoSmithKline in roles such as Global Process Owner/Safety Lead (2018–present), Country Medical Director (2015–2018), and Regulatory Affairs Manager (2010–2014). His career also includes roles at Serbia’s Medicines and Medical Devices Agency, including Director of the National Pharmacovigilance Centre (2007–2010).

Education:

• PharmD, Faculty of Pharmacy, University of Belgrade (1993–1999)
• Postgraduate Studies in Pharmacokinetics/Clinical Pharmacokinetics (1999–2005)
• Doctoral Studies in Bio-pharmaceutics (2007–2010)
• Specialist Studies in Clinical Pharmacy (2004–2008)

Research Expertise: Focuses on drug absorption modeling, regulatory compliance, and pharmacovigilance. Notable contributions include developing in vitro-in vivo correlation (IVIVC) models for drug bioequivalence, integrating gastrointestinal simulation and artificial neural networks for drug absorption prediction, and advancing methods for evaluating biowaivers. His work bridges pharmaceutical science with regulatory practice, particularly in low-soluble/high-permeable drugs.

Awards:

• University of Belgrade’s Best Graduate Award (1999)
• Professor Ivan Berkeš Award for Academic Excellence (1999)
• GlaxoSmithKline „Gold“ Team Member Award
• Scientific Associate Title at University of Belgrade’s Faculty of Pharmacy (2013)

Professional Activities: Involved in Serbia’s regulatory framework development through EU-funded projects (e.g., ALIMS-AFSSAPS collaboration), mentoring PhD students on in silico drug absorption, and contributing to postgraduate education in pharmacovigilance and industrial pharmacy. Active in Serbian pharmaceutical societies and committees.